Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Merck Covid Pill Set for Authorization Despite Concerns, MS Says
2 Merck Closes Deal for Acceleron Pharma, Biggest Biotech Merger of the Year
3 Merck says its Covid antiviral treatment less effective than first thought
4 U.K. Set to Deploy Merck's Covid Pill in 10000-Person Study
5 Lab worker finds vials labeled ‘smallpox’ at Merck facility
6 Merck asks EU regulator to authorize its COVID-19 pill
7 U.S. government to buy $1 billion more worth of Merck's COVID-19 pill
8 Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo
9 Merck to Present at the 4th Annual Evercore ISI HealthCONx Conference
10 US to Spend $1 Billion More on Merck COVID-19 Pills
11 Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
12 Merck's Covid Antiviral Is a Long-Term Win for Revenue
13 Why You Can't Afford Not to Buy Merck's Stock
14 Merck Highlights Novel Mechanisms with the Potential to Transform Standards of Care in Several Cancers, MS, and Lupus
15 Merck will support Saudi Arabia effort to build biologics manufacturing operations
16 Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators' review time only one benefit
17 Merck Receives Another Boost for Its Top-Selling Drug
18 What’s Next For Merck Stock After An Upbeat Q3?
19 Indonesia reviewing Merck COVID-19 pill, up to 1 mln doses targeted
20 Warren Buffett's Berkshire Hathaway Sells Merck Shares, Buys Royalty Pharma
21 Here's Why Merck Stock Vaulted Higher in October
22 Better Buy: Bristol Myers Squibb vs. Merck
23 Better COVID Stock: Merck vs. Pfizer
24 Merck's Plan B Percolates After Pfizer Announces Dominance
25 Merck and Ridgeback to Present Phase 3 Data for Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, at American Society of Tropical Medicine and Hygiene (ASTMH) 2021 Annual Meeting
26 Dow Jones Gains 300 Points on Jobs Report, Merck Shares Slammed on Pfizer's COVID Pill Results
27 Months after a Merck spinout, Organon continues its string of deals with a $954M buyout package
28 Merck Says It's Working With China to Bring In Its Covid Pill
29 Merck dives even further into cytokine research as deal spree continues
30 A new boss, a new path forward and new challenges for N.J. pharma giant
31 Merck Announces Receipt of Antitrust Clearance in Germany and Austria Relating to Tender Offer to Acquire Acceleron Pharma Inc.
32 Merck stock's biggest selloff in nearly 17 years is cutting close to 60 points off the Dow's price
33 The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
34 Merck HIV combo sees approval chances soar to 99%: regulatory roundup
35 FDA unlikely to rule on Merck's COVID pill before December
36 Merck says COVID-19 pill cuts risk of death, hospitalization
37 Merck comms lead Cristal Downing talks revitalizing trust in big pharma
38 Merck's (NYSE:MRK) Balance Sheet Can Easily Handle Acquisitions like Acceleron Pharma (NASDAQ: XLRN)
39 Pneumococcal Vaccines Market Snapshot: Pfizer And Merck Face Off
40 Merck COVID-19 pill sparks calls for access for lower income countries
41 Merck KGaA's Schistosomiasis Drug Shows Positive Results in Phase-3 Children Trial
42 Pharmaceutical Stock Ani Rockets After Winning FDA Approval To Revive Old Merck Drug
43 Merck ahead of Pfizer in EU talks on COVID-19 pills -EU source
44 Dow jumps 100 points on gains for shares of Merck, Goldman Sachs
45 Merck-Pfizer immunotherapy gets expanded indication for urothelial cancer
46 [NEWS IN FOCUS] Merck's magic pill trashed as Regkirona pushed in Korea
47 Pfizer, Merck launch new trials of oral COVID-19 drugs
48 Merck to buy Acceleron for about $11.5 billion in rare-disease drugs push
49 Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop
50 A bear and a bull debate the move in health care after Merck’s Covid pill breakthrough
51 U.S. signs $1.2 bln deal for 1.7 mln courses of Merck's experimental COVID-19 drug
52 What’s Next For Merck Stock After A 5% Fall In A Week?
53 Merck's Gesture to Save Humanity From COVID-19
54 Merck and Singapore sign deal on COVID-19 antiviral pill
55 Merck, Evidation join forces on Alzheimer's data solutions
56 Merck investigating noose at NC vaccine plant as execs pledge swift response
57 Merck Sales Beat Estimates, But the Stock Fell. Here’s 1 Reason to Be Bullish.
58 Biogen, mRNA players on Merck's M&A radar as CEO still hungry for deals after $11.5B Acceleron buy: FT
59 Merck drug less effective against moderate COVID -India regulatory source
60 Merck ends development of Covid drug it acquired from OncoImmune
61 Merck taps longtime insider Klobuchar to lead strategy after clinching $9B from Organon split
62 Merck KGaA, GSK end partnership on former cancer drug hopeful
63 U.S. drugmaker Merck sees bigger hit to full-year sales from pandemic
64 Merck sees potential U.S. authorization for COVID-19 antiviral before year-end
65 Whistleblower says FDA minimized safety risks at Merck vaccine plant
66 Merck begins late-stage trial of experimental COVID-19 drug
67 Gov. DeSantis eyeing development of Merck's new anti-COVID pharmaceutical
68 New antiviral drug from Merck could help reduce COVID hospitalizations and deaths
69 VERIFY: No, Merck's investigational COVID-19 pill is not a 'rebranded' Ivermectin
70 After $600M sales hit from pandemic, Merck's open to 'all forms' of M&A deals, incoming CEO says
71 Stocks making the biggest moves midday: Merck, Moderna, United Airlines and more
72 Independent from Merck, Organon CEO lays out newco's women's health ambitions, M&A plans
73 Merck, Codexis extend supply deal for key API in Januvia, Janumet
74 Merck's Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected
75 German to weigh need to purchase Merck & co's COVID-19 drug
76 Gilead, Merck and others slapped with 'pay-for-delay' lawsuits over lucrative HIV and cholesterol meds
77 Merck will help make Johnson & Johnson coronavirus vaccine as rivals team up to help Biden accelerate shots
78 Merck taps Xeris for ready-to-use versions of antibody products
79 Merck develops new technology to address solubility and speed to market challenges of ADCs
80 Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst
81 Merck Issues Voluntary Nationwide Recall of CUBICIN® (Daptomycin for Injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles
82 Can Merck's new boss maintain the drugmaker's winning streak?
83 Merck, Pfizer's Wyeth settle pneumococcal vaccine patent dispute
84 Merck KGaA says lab supplies business can grow by up to 10% per year
85 WHO says seeks more data from Merck on COVID anti-viral, from Bharat on vaccine
86 As Congress considers drug price reforms, Merck, Lilly and Takeda execs warn of dire consequences
87 Merck researcher who studied ivermectin worries about misuse for COVID-19 treatment
88 Merck's Ken Frazier Named CEO of the Year
89 Merck has better luck with 2nd COVID-19 drug attempt as it sees a positive in early molnupiravir data
90 Britain secures COVID-19 antivirals from Merck and Pfizer
91 India's Optimus Pharma seeks approval to produce generic Merck COVID-19 pill
92 Johns Hopkins to host conversation with Merck CEO Robert Davis
93 Merck joins other drugmakers in cutting off sales to 340B contract pharmacies
94 How Merck's Vaccine Lost the Covid Race
95 Merck Will Help Manufacture Johnson & Johnson's COVID-19 Vaccine
96 Merck taps five Indian drugmakers to expand COVID-19 drug production
97 Merck strikes deal for global access to Covid drug
98 CNBC Transcript: Merck President & CEO Robert Davis Speaks with CNBC’s “Squawk Box” Today
99 Merck to Hold Third-Quarter 2021 Sales and Earnings Conference Call on October 28
100 Organon shares jump as Merck's new women's health spinoff posts strong start for biosims, infertility drugs